Abbott traded at $110.55 this Thursday August 18th, decreasing $1.48 or 1.32 percent since the previous trading session. Looking back, over the last four weeks, Abbott lost 0.56 percent. Over the last 12 months, its price fell by 12.07 percent. Looking ahead, we forecast Abbott to be priced at 108.36 by the end of this quarter and at 99.51 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
110.55
Daily Change
-1.32%
Yearly
-12.07%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Terumo 4,615.00 -109.00 -2.31% 2.56%
Agilent 142.29 9.52 7.17% -12.72%
Abiomed 281.82 -9.30 -3.19% -14.81%
Abbott 110.55 -1.48 -1.32% -12.07%
AtriCure 50.55 -2.06 -3.92% -30.73%
Baxter International 61.38 -0.46 -0.74% -18.45%
Becton, Dickinson and Co. 264.23 -3.55 -1.33% 6.60%
Bio-Rad Laboratories 524.11 -9.86 -1.85% -32.00%
Boston Scientific 42.43 0.08 0.19% -3.77%
Cooper Companies 329.07 -8.20 -2.43% -23.93%
Cardiovascular Systems 16.19 -0.53 -3.17% -55.05%
Danaher 297.27 -3.21 -1.07% -7.04%
Dexcom 88.14 -2.65 -2.92% -30.81%
Edwards Lifesciences 100.53 -1.75 -1.71% -13.53%
Globus Medical 66.52 -0.54 -0.81% -13.42%
Hologic 71.89 -0.96 -1.32% -5.76%
Integra LifeSciences 54.88 -0.92 -1.65% -23.41%
Intuitive Surgical 229.71 -4.00 -1.71% -34.72%
J&J 167.58 0.01 0.01% -5.42%
Masimo 165.54 -3.84 -2.27% -39.40%
Medtronic 94.91 -0.40 -0.42% -26.39%
Merit Medical Systems 62.01 -1.31 -2.07% -7.50%
NuVasive 50.44 -1.54 -2.96% -14.77%
Pfizer 49.27 -0.59 -1.18% -0.08%
Insulet 266.60 -2.01 -0.75% -10.24%
Smith & Nephew PLC 1,035.50 0 0% -26.53%
Stryker 221.43 -2.73 -1.22% -16.23%
Teleflex 244.94 -8.17 -3.23% -34.15%
Thermo Fisher Scientific 596.04 -6.07 -1.01% 8.00%
Tandem Diabetes Care 52.81 -1.94 -3.54% -52.75%
Zimmer Biomet Holdings Inc 114.64 -1.48 -1.27% -20.60%

Indexes Price Day Year
US500 4276 -31.16 -0.72% -2.94%

Abbott
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.